##gff-version 3
##sequence-region P50995 1 505
P50995	UniProtKB	Chain	1	505	.	.	.	ID=PRO_0000067510;Note=Annexin A11	
P50995	UniProtKB	Repeat	209	269	.	.	.	Note=Annexin 1	
P50995	UniProtKB	Repeat	281	341	.	.	.	Note=Annexin 2	
P50995	UniProtKB	Repeat	365	425	.	.	.	Note=Annexin 3	
P50995	UniProtKB	Repeat	440	500	.	.	.	Note=Annexin 4	
P50995	UniProtKB	Modified residue	248	248	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P50995	UniProtKB	Modified residue	255	255	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P50995	UniProtKB	Modified residue	479	479	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P50995	UniProtKB	Alternative sequence	1	33	.	.	.	ID=VSP_054553;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P50995	UniProtKB	Natural variant	38	38	.	.	.	ID=VAR_080653;Note=In ALS23%3B unknown pathological significance%3B changed cytoplasmic localization with decreased association with vesicle-like structures%3B increased interaction with S100A6. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28469040;Dbxref=dbSNP:rs142083484,PMID:28469040	
P50995	UniProtKB	Natural variant	40	40	.	.	.	ID=VAR_080654;Note=In ALS23%3B forms cytoplasmic aggregates in patient tissues%3B no effect on nuclear and cytoplasmic localization%3B loss of interaction with S100A6. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28469040;Dbxref=dbSNP:rs1247392012,PMID:28469040	
P50995	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_080655;Note=In ALS23%3B unknown pathological significance. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28469040;Dbxref=dbSNP:rs754594235,PMID:28469040	
P50995	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_080656;Note=In ALS23%3B unknown pathological significance%3B no effect on aggregation%3B loss of interaction with S100A6. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28469040;Dbxref=dbSNP:rs569546089,PMID:28469040	
P50995	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_048259;Note=R->Q;Dbxref=dbSNP:rs2229554	
P50995	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_012006;Note=R->C;Dbxref=dbSNP:rs1049550	
P50995	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_080657;Note=In ALS23%3B unknown pathological significance%3B increased aggregation in the cytoplasm sequestering the wild-type protein in these aggregates%3B loss of interaction with S100A6. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28469040;Dbxref=dbSNP:rs765489119,PMID:28469040	
P50995	UniProtKB	Natural variant	346	346	.	.	.	ID=VAR_080658;Note=In ALS23%3B unknown pathological significance. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28469040;Dbxref=dbSNP:rs770574196,PMID:28469040	
P50995	UniProtKB	Natural variant	457	457	.	.	.	ID=VAR_012007;Note=I->V;Dbxref=dbSNP:rs1802932	
